SES AI Corp
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
RDDT Stock Is In The Limelight Today After Massive Pre-Market Fall — GOOGL Friction Raises AI Licensing Risks, Says Wells Fargo
The selloff in Reddit shares came as investors looked past the earnings beat and focused on slowing U.S. user growth and management's commentary on its relationship with Google.
Morgan Stanley Says Amazon, Microsoft, and Google's AI Spending Will Pay Off Big
Morgan Stanley Dismisses AI Spending Fears With Bullish Call on Big Tech
MSFT Stock Soars After Results: CFO Dismisses AI Overcapacity Narrative, Says Can Rein In Spending If Demand Changes
Microsoft beat fourth-quarter sales and profit expectations, with its Azure cloud posting 43% growth.
Yoodli Appoints Former Meta and Coalition Product Leader Kartik Murthy as VP of Product
Yoodli, the AI-powered experiential learning platform that uses AI roleplays to help teams practice high-stakes conversations, today announced the appointment of Kartik Murthy as Vice President of Product. Murthy officially joins the company July 27 and will lead product strategy and execution as Yoodli scales its platform for global revenue teams.
Vandenberg Space Force Base Loses Airman 1st Class Cedric Eneluna in On-Base Accident - News Channel 3-12
Advanced Micro Devices vs. Texas Instruments: Which Technology Stock Is a Better Buy in 2026?
AMD chases AI growth with concentrated risk, while TXN's diversified portfolio trades at a cheaper valuation. Which risk-reward profile fits your 2026 strategy?
SambaNova raises $1 billion Series F at $11 billion valuation
General Atlantic led the round, and JPMorgan Chase signed on as a customer to deploy SambaNova's chips for on-premises AI inference
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profiles stack up?
Stock market today: Dow, S&P 500, Nasdaq futures rise as Micron eases AI jitters ahead of PCE
EssilorLuxottica and Meta expand the accessibility of wearables category with new collection
EssilorLuxottica and Meta expand the accessibilityof wearables category with new collection Building on their market-leading portfolio of AI glasses, the two companies aim to introduce more consumers to smart eyewear innovation Paris, France and Menlo Park, CA (23 June 2026) – EssilorLuxottica and Meta announced the launch of Meta Glasses, a new collection of AI glasses aimed at opening up the smart eyewear category to broader audiences, including consumers looking for more attainable innovation
Congressional Trades in $SES
No disclosed congressional trades found in $SES.
Insider Trades (Form 4)
Liu Yi Ray
Pilkington Kyle
Xu Kang
Hu Qichao
Boyd Andrew J
Luo Eric
Key People
Xu Kang
CHIEF TECHNOLOGY OFFICER
Hu Qichao
CEO & CHAIRMAN
Pilkington Kyle
CHIEF LEGAL OFFICER
Luo Eric
Director
Boyd Andrew J
Director
Liu Yi Ray
CHIEF FINANCIAL OFFICER
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro